local_hospital

Centre Hospitalier Interciommunal Elbeuf, Louviers, Val de Reuil

Address
Hôpital Feugrais, Rue du Docteur Villers, 76410 Saint Aubin Les Elbeuf, France

Centre Hospitalier Interciommunal Elbeuf, Louviers, Val de Reuil

Centre Hospitalier Interciommunal Elbeuf, Louviers, Val de Reuil is a multidisciplinary research center conducting advanced clinical investigations across critical care medicine, oncology, and endocrinology. The center demonstrates particular expertise in innovative therapeutic approaches for life-threatening conditions and chronic disease management, with a focus on precision medicine and patient-centered interventions.

  • Critical care research in septic shock management, investigating novel cardiovascular interventions including beta-blocker therapy for hypercontractility-associated tachycardia
  • Oncology trials in non-small-cell lung cancer, evaluating immunotherapy combinations and optimal first-line treatment strategies for PD-L1 positive tumors
  • Endocrinology and diabetes research focusing on gastric motility disorders and glycemic control optimization in Type 1 diabetes patients

The research portfolio reflects the center's commitment to addressing complex clinical challenges through randomized controlled trials and comparative effectiveness studies. Their work spans from acute life-threatening conditions such as septic shock to chronic metabolic disorders, emphasizing the development of targeted interventions that can improve patient outcomes through mechanisms such as heart rate modulation, immunotherapy optimization, and gastric motility enhancement in digestively asymptomatic diabetic populations.

Site Overview

assignment
4
connected trials
corporate_fare
3
sponsors
science
5
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
3
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
4
Outperforms 60% of sites
public
Therapeutic diversity
5areas
Outperforms 73% of sites
groups
Sponsor diversity
3sponsors
Outperforms 57% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier Interciommunal Elbeuf, Louviers, Val de Reuil

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy of Iloprost for the Management of Vaso-Occlusive Crises in Adults with Sickle Cell Disease: A Randomized, Double-Blind, Placebo-Controlled StudyCentre Hospitalier Universitaire RouenPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Domperidone1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.